
Novel Food in the EU: how to check ingredient status before you formulate

EU Market
Few things derail a product launch faster than discovering, late in development, that a key ingredient cannot legally be sold in the EU without authorisation. That is the risk the Novel Food rules are designed around — and the reason ingredient status is something to check at the very start of formulation, not the end.
What counts as a Novel Food?
Under Regulation (EU) 2015/2283, a Novel Food is any food or food ingredient that was not used for human consumption to a significant degree within the EU before 15 May 1997.
That cut-off date is the heart of the definition. If an ingredient has a meaningful history of consumption in the EU before then, it is generally not novel. If it does not — because it is newly developed, newly isolated, produced by a new process, or traditionally eaten only outside the EU — it may fall under the Novel Food rules.
The category is broad. It can include extracts, ingredients from new sources, products of new production processes, and foods traditional in other parts of the world but new to the EU market.
Why status has to be checked before formulating
If an ingredient is novel and has not been authorised, it cannot be placed on the EU market until it goes through the authorisation procedure — a process that involves a safety assessment and can take a significant amount of time.
For a manufacturer, that has a hard consequence: building a formula around an unauthorised novel ingredient means the product cannot legally launch, no matter how good it is. Discovering this after the formula is set, the packaging is designed, and the spec sheet is written is an expensive way to learn the rule.
Checking status first means the question "can we even sell this?" is answered before any development effort goes in.
The three outcomes you are checking for
When you check an ingredient, you are essentially sorting it into one of three buckets:
Not novel. It has a significant history of consumption in the EU before the cut-off, or is otherwise outside the scope. It can be used under the normal rules.
Novel and authorised. It is novel, but it has already been through authorisation and appears on the Union list — usually with specific conditions of use, such as permitted categories, maximum levels, and labeling requirements. You can use it, but only within those conditions.
Novel and not authorised. It is novel and has no authorisation. It cannot be used until that changes.
The middle bucket is the one teams most often get wrong — an ingredient can be perfectly legal but only under conditions that the formula has to respect.
How to check
The EU maintains a Novel Food catalogue and a Union list of authorised novel foods. The practical workflow is to identify each ingredient precisely (the exact source and form matter), check whether it appears as novel, and if so, whether it is authorised and under what conditions.
The difficulty is that this is not a one-time check. Ingredient sources change, suppliers change specifications, and the lists are updated as new authorisations come through. A check done once at the start of a product's life is not the same as knowing the status of every ingredient in your current catalogue.
Building the check into formulation
The ideal is for novel status to surface the moment an ingredient is added to a formula — flagged as not novel, authorised with conditions, or not authorised — rather than living in a separate document someone has to remember to consult.
When the status travels with the ingredient, the "can we sell this?" question is answered continuously, and a problem ingredient is caught while the formula is still on the screen.
The takeaway
Novel Food status is a go/no-go question that belongs at the start of formulation. The definition turns on a 1997 cut-off; the outcomes are not-novel, authorised-with-conditions, or not-authorised; and the real discipline is keeping that status visible for every ingredient, every time, as lists and supplier specs change.
Lemoniq surfaces novel ingredient status as you formulate, so a no-go ingredient is caught before development starts — not after. See how it works
Share this article
Relevans posts
Welcome back
What are we formulating today, George?



